Overview


According to FutureWise analysis the market for allergy diagnostics and therapeutics in 2023 is US$ 31.36 billion, and is expected to reach US$ 53.17 billion by 2031 at a CAGR of 6.80%.

Allergies are harmless substances that cause an allergic reaction from the immune system. Many individuals with allergens may also experience asthma symptoms, such as wheezing and difficulty breathing. The air spreads allergens around. They settle onto furniture, grass, pillows, mattresses, or floors. They differ in size and are measured in microns (also called micrometers). The rising incidence of allergies, such as common triggers like dust mites, pollen, and pet dander, is increasing and causing chronic illness. The severity of allergies varies, ranging from mild discomfort to a life-threatening condition known as anaphylaxis. Although there is no permanent cure for most allergies, treatments are available to relieve symptoms and improve quality of life.

The allergy diagnosis is based on a medical history of allergic symptoms and diagnostic tests. It is strongly suspected when two or more symptoms of watery rhinorrhea, sneezing, nasal obstruction, and nasal pruritus persist for ≥1 hour on most days. Immunotherapy is one of the most common treatment options for some allergy patients. There are two types of immunotherapy: sublingual immunotherapy (SLIT) and allergy shots. Allergy shots involve administering gradually increasing doses of allergens through injections over a period of time. The individual becomes progressively less sensitive to that allergen. Allergy shots can work well for some individuals with allergies to pollen, pets, dust, bees, other stinging insects, and asthma. Allergy shots do not usually work for allergies to food, medicines, feathers, hives, or eczema. Sublingual Immunotherapy (SLIT) is another alternative to treat allergies without the need for injections. Allergists give patients with small doses of an allergen under the tongue. This improves tolerance to the substance and reduces symptoms. SLIT is relatively safe and effective for treating nasal allergies and asthma. Also, several drugs are available to reduce allergy symptoms, such as antihistamines, decongestants, mast cell stabilizers, etc.

FutureWise Market Research has published a report that provides an insightful allergy diagnostics and therapeutics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, allergy diagnostics and therapeutics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  •  bioMerieux
  •  Danaher Corporation
  •  Thermo Fisher Scientific
  •  Stallergenes Greer
  •  Hitachi Chemical Diagnostics
  •  Siemens Healthcare
  •  Omega Diagnostics
  •  Hycor Biomedical
  •  Lincoln Diagnostics
  •  HOB Biotech Group
  •  Alcon Laboratories, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Allergy Diagnostics and Therapeutics Market:

  • In October 2022, Allergy Partners announced a partnership with Aimmune Therapeutics Inc., a Nestlé Health Science Company. As per the deal, patients aged 4 to 17 years with confirmed peanut allergy diagnosis will get direct access to PALFORZIA, the only peanut allergy treatment approved by FDA.

  • In August 2022, STAT Medical introduced its inaugural product line, including user-friendly at-home allergy test kits. These kits enable individuals to conduct self-screening for a wide array of prevalent food and respiratory allergies using a single finger prick.

The rising prevalence of allergies, including pollution, dietary changes, and an increasing prevalence of genetic predispositions, may increase the demand for allergy diagnostics and therapeutics market during the projected period. Growing exposure to environmental pollutants and allergens, along with evolving dietary patterns and genetic susceptibilities, contribute to the increasing occurrence of allergies worldwide. As individuals grapple with these allergic triggers, there is a growing demand for advanced diagnostic tools and effective therapeutic interventions, further propelling market growth. Additionally, the rising demand for home testing services is a significant driver in the healthcare industry. This surge might be attributed to several factors, such as convenience, privacy, and accessibility. In an era where individuals prioritize efficient healthcare experiences, the ability to conduct diagnostic tests from the comfort of one's own home has gained significance. Furthermore, technological advancements have enabled the development of user-friendly testing kits, further bolstering the appeal of this convenient and time-saving alternative to traditional clinical visits, which is further anticipated to boost market growth. However, poor assessment of ingredient specifications and the presence of allergens in trace amounts within various ingredients will likely restrain the market growth. This management poses a significant risk to consumers with severe allergies, potentially leading to adverse reactions. It risks product safety and erodes consumer trust and confidence, further hindering the market growth. Moreover, the high cost of allergy diagnostics and therapeutics poses a substantial constraint to the market growth. This financial burden may present an obstacle to developing regions and individuals with limited economic resources, further hindering the growth of the allergy diagnostic and therapeutic market.

By Product

  •  Instruments
  •  Consumables
  •  Services

By Allergen Type

  •  Food
  •  Inhaled
  •  Drug
  •  Other

By End Use

  •  Diagnostic Laboratories
  •  Hospitals
  •  Academic Research Institutes

By Diagnostic Test

  •  In vivo Test
    •  Skin Prick Test
    •  Intradermal Test
    •  Patch Test
  •  In vitro Test

By Drug Class

  •  Antihistamines
  •  Decongestants
  •  Corticosteroids
  •  Mast Cell Stabilizers
  •  Leukotriene Inhibitors
  •  Nasal Anticholinergics
  •  Immunomodulators
  •  Autoinjectable Epinephrine
  •  Immunotherapy

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to factors such as well-established healthcare expenditure, the rising incidences of allergies, favorable government initiatives,  growing awareness among consumers, regarding the potential of early diagnosis and therapeutics of allergies, advancements in allergy drugs, and increasing IgE inflammatory response in the nasal mucosa following exposure to allergens that are sensitized to symptoms mainly include rhino rhea and nasal congestion, sneezing, pruritus, and eye signs such as redness and itching/watery eyes in the region is expected to drive the growth of allergy diagnostics and therapeutics market. For instance, exemplified in the report from the Asthma and Allergy Foundation of America, the yearly expenditure of nasal allergies in the region ranges between USD 3-4billion. Hence, the above-mentioned factors will likely propel the market expansion over the forecast period.

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  •  To provide with an exhaustive analysis on the Allergy Diagnostics and Therapeutics Market By Product, By Allergen Type, By End Use, By Diagnostic Test, By Drug Class and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Allergy Diagnostics and Therapeutics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Allergy Diagnostics and Therapeutics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Allergy Diagnostics and Therapeutics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Allergy Diagnostics and Therapeutics Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Instruments
        2. Consumables
        3. Services

  • 8.   Allergy Diagnostics and Therapeutics Market, By Allergen Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Food
        2. Inhaled
        3. Drug
        4. Others

  • 9.   Allergy Diagnostics and Therapeutics Market, By End Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostic Laboratories
        2. Hospitals
        3. Academic Research Institutes

  • 10.   Allergy Diagnostics and Therapeutics Market, By Diagnostic Test Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. In vivo Test
         1.1. Skin Prick Test
         1.2. Intradermal Test
         1.3. Patch Test
        2. In vitro Test

  • 11.   Allergy Diagnostics and Therapeutics Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Antihistamines
        2. Decongestants
        3. Corticosteroids
        4. Mast Cell Stabilizers
        5. Leukotriene Inhibitors
        6. Nasal Anticholinergics
        7. Immunomodulators
        8. Autoinjectable Epinephrine
        9. Immunotherapy

  • 12.   North America Allergy Diagnostics and Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Allergy Diagnostics and Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Allergy Diagnostics and Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Allergy Diagnostics and Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. bioMerieux
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Danaher Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Thermo Fisher Scientific
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Stallergenes Greer
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hitachi Chemical Diagnostics
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Siemens Healthcare
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Omega Diagnostics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Hycor Biomedical
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Lincoln Diagnostics
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. HOB Biotech Group
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
          11. Alcon Laboratories, Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client

Related Market

Allergy Diagnostics Market

Read More

Allergy Diagnostic Assay Kits Market

Read More
Partner

Our Clients